Cargando…

Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease

BACKGROUND: This study aimed to investigate the pathophysiology of hepatic microcirculatory dysfunction in non-alcoholic fatty liver disease (NAFLD). METHODS: In Wistar rats, NAFLD model was induced by 20 weeks of high-fat diet (HFD) feeding. Rolling and adhesion of leukocytes and tissue perfusion i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Evelyn Nunes Goulart da Silva, Silvares, Raquel Rangel, Flores, Edgar Eduardo Ilaquita, Rodrigues, Karine Lino, Ramos, Isalira Peroba, da Silva, Igor José, Machado, Marcelo Pelajo, Miranda, Rosiane Aparecida, Pazos-Moura, Carmen Cabanelas, Gonçalves-de-Albuquerque, Cassiano F., Faria-Neto, Hugo Caire de Castro, Tibiriça, Eduardo, Daliry, Anissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476253/
https://www.ncbi.nlm.nih.gov/pubmed/28628674
http://dx.doi.org/10.1371/journal.pone.0179654
_version_ 1783244577462812672
author Pereira, Evelyn Nunes Goulart da Silva
Silvares, Raquel Rangel
Flores, Edgar Eduardo Ilaquita
Rodrigues, Karine Lino
Ramos, Isalira Peroba
da Silva, Igor José
Machado, Marcelo Pelajo
Miranda, Rosiane Aparecida
Pazos-Moura, Carmen Cabanelas
Gonçalves-de-Albuquerque, Cassiano F.
Faria-Neto, Hugo Caire de Castro
Tibiriça, Eduardo
Daliry, Anissa
author_facet Pereira, Evelyn Nunes Goulart da Silva
Silvares, Raquel Rangel
Flores, Edgar Eduardo Ilaquita
Rodrigues, Karine Lino
Ramos, Isalira Peroba
da Silva, Igor José
Machado, Marcelo Pelajo
Miranda, Rosiane Aparecida
Pazos-Moura, Carmen Cabanelas
Gonçalves-de-Albuquerque, Cassiano F.
Faria-Neto, Hugo Caire de Castro
Tibiriça, Eduardo
Daliry, Anissa
author_sort Pereira, Evelyn Nunes Goulart da Silva
collection PubMed
description BACKGROUND: This study aimed to investigate the pathophysiology of hepatic microcirculatory dysfunction in non-alcoholic fatty liver disease (NAFLD). METHODS: In Wistar rats, NAFLD model was induced by 20 weeks of high-fat diet (HFD) feeding. Rolling and adhesion of leukocytes and tissue perfusion in hepatic microcirculation were examined using in vivo microscopic and laser speckle contrast imaging (LSCI), respectively. Oxidative stress and inflamatory parameters were analysed by TBARs, catalase enzyme activity, RT-PCR and ELISA. The participation of advanced glycation end-products (AGE) and its receptor RAGE was evaluated by the measurement of gene and protein expression of RAGE by RT-PCR and Western-blot, respectively and by liver and serum quantification of fluorescent AGEs. RESULTS: Wistar rats fed high-fat diet (HFD) showed increase in epididymal and abdominal fat content, systolic arterial blood pressure, fasting blood glucose levels, hepatic triglycerides and cholesterol, and impairment of glucose and insulin metabolisms. Liver histology confirmed the presence of steatosis and ultrasound analysis revealed increased liver size and parenchymal echogenicity in HFD-fed rats. HFD causes significant increases in leukocyte rolling and adhesion on hepatic microcirculation and decrease in liver microvascular blood flow. Liver tissue presented increase in oxidative stress and inflammtion. At 20 weeks, there was a significantly increase in AGE content in the liver and serum of HFD-fed rats and an increase in RAGE gene expression in the liver. CONCLUSION: The increase in liver AGE levels and microcirculatory disturbances could play a role in the pathogenesis of liver injury and are key components of NAFLD.
format Online
Article
Text
id pubmed-5476253
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-54762532017-07-03 Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease Pereira, Evelyn Nunes Goulart da Silva Silvares, Raquel Rangel Flores, Edgar Eduardo Ilaquita Rodrigues, Karine Lino Ramos, Isalira Peroba da Silva, Igor José Machado, Marcelo Pelajo Miranda, Rosiane Aparecida Pazos-Moura, Carmen Cabanelas Gonçalves-de-Albuquerque, Cassiano F. Faria-Neto, Hugo Caire de Castro Tibiriça, Eduardo Daliry, Anissa PLoS One Research Article BACKGROUND: This study aimed to investigate the pathophysiology of hepatic microcirculatory dysfunction in non-alcoholic fatty liver disease (NAFLD). METHODS: In Wistar rats, NAFLD model was induced by 20 weeks of high-fat diet (HFD) feeding. Rolling and adhesion of leukocytes and tissue perfusion in hepatic microcirculation were examined using in vivo microscopic and laser speckle contrast imaging (LSCI), respectively. Oxidative stress and inflamatory parameters were analysed by TBARs, catalase enzyme activity, RT-PCR and ELISA. The participation of advanced glycation end-products (AGE) and its receptor RAGE was evaluated by the measurement of gene and protein expression of RAGE by RT-PCR and Western-blot, respectively and by liver and serum quantification of fluorescent AGEs. RESULTS: Wistar rats fed high-fat diet (HFD) showed increase in epididymal and abdominal fat content, systolic arterial blood pressure, fasting blood glucose levels, hepatic triglycerides and cholesterol, and impairment of glucose and insulin metabolisms. Liver histology confirmed the presence of steatosis and ultrasound analysis revealed increased liver size and parenchymal echogenicity in HFD-fed rats. HFD causes significant increases in leukocyte rolling and adhesion on hepatic microcirculation and decrease in liver microvascular blood flow. Liver tissue presented increase in oxidative stress and inflammtion. At 20 weeks, there was a significantly increase in AGE content in the liver and serum of HFD-fed rats and an increase in RAGE gene expression in the liver. CONCLUSION: The increase in liver AGE levels and microcirculatory disturbances could play a role in the pathogenesis of liver injury and are key components of NAFLD. Public Library of Science 2017-06-19 /pmc/articles/PMC5476253/ /pubmed/28628674 http://dx.doi.org/10.1371/journal.pone.0179654 Text en © 2017 Pereira et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Pereira, Evelyn Nunes Goulart da Silva
Silvares, Raquel Rangel
Flores, Edgar Eduardo Ilaquita
Rodrigues, Karine Lino
Ramos, Isalira Peroba
da Silva, Igor José
Machado, Marcelo Pelajo
Miranda, Rosiane Aparecida
Pazos-Moura, Carmen Cabanelas
Gonçalves-de-Albuquerque, Cassiano F.
Faria-Neto, Hugo Caire de Castro
Tibiriça, Eduardo
Daliry, Anissa
Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease
title Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease
title_full Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease
title_fullStr Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease
title_full_unstemmed Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease
title_short Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease
title_sort hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476253/
https://www.ncbi.nlm.nih.gov/pubmed/28628674
http://dx.doi.org/10.1371/journal.pone.0179654
work_keys_str_mv AT pereiraevelynnunesgoulartdasilva hepaticmicrovasculardysfunctionandincreasedadvancedglycationendproductsarecomponentsofnonalcoholicfattyliverdisease
AT silvaresraquelrangel hepaticmicrovasculardysfunctionandincreasedadvancedglycationendproductsarecomponentsofnonalcoholicfattyliverdisease
AT floresedgareduardoilaquita hepaticmicrovasculardysfunctionandincreasedadvancedglycationendproductsarecomponentsofnonalcoholicfattyliverdisease
AT rodrigueskarinelino hepaticmicrovasculardysfunctionandincreasedadvancedglycationendproductsarecomponentsofnonalcoholicfattyliverdisease
AT ramosisaliraperoba hepaticmicrovasculardysfunctionandincreasedadvancedglycationendproductsarecomponentsofnonalcoholicfattyliverdisease
AT dasilvaigorjose hepaticmicrovasculardysfunctionandincreasedadvancedglycationendproductsarecomponentsofnonalcoholicfattyliverdisease
AT machadomarcelopelajo hepaticmicrovasculardysfunctionandincreasedadvancedglycationendproductsarecomponentsofnonalcoholicfattyliverdisease
AT mirandarosianeaparecida hepaticmicrovasculardysfunctionandincreasedadvancedglycationendproductsarecomponentsofnonalcoholicfattyliverdisease
AT pazosmouracarmencabanelas hepaticmicrovasculardysfunctionandincreasedadvancedglycationendproductsarecomponentsofnonalcoholicfattyliverdisease
AT goncalvesdealbuquerquecassianof hepaticmicrovasculardysfunctionandincreasedadvancedglycationendproductsarecomponentsofnonalcoholicfattyliverdisease
AT farianetohugocairedecastro hepaticmicrovasculardysfunctionandincreasedadvancedglycationendproductsarecomponentsofnonalcoholicfattyliverdisease
AT tibiricaeduardo hepaticmicrovasculardysfunctionandincreasedadvancedglycationendproductsarecomponentsofnonalcoholicfattyliverdisease
AT daliryanissa hepaticmicrovasculardysfunctionandincreasedadvancedglycationendproductsarecomponentsofnonalcoholicfattyliverdisease